Eastman Chemical Company (EMN)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
$71.19+0.59%
Close 2026-09-04 · 1-day change
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
QuarterlyIQ Insights · EMN
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 9 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $71 EMN trades at 14× p/e, below its 17× p/e peer median. Our $88 fair value sits above the price. It's a high-confidence read. Analysts target $74–$92. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $77.00 | — | — | Analyst | high |
| ddm gordon | 12M | $48.59 | — | — | TTM | high |
| graham number | 12M | $77.23 | — | — | TTM | high |
| Peer EV/EBITDA | 12M | $131.09 | 10.0 | 12.49 | TTM | high |
| Peer P/E | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$74.00 – $92.00 (median $77.00) · 4 analysts · as of 2026-08-03
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Self-history needs ~20 months of data.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $85.91 |
| 17.4 |
| 4.95 |
| TTM |
| high |
| Peer P/S | 12M | $111.40 | 1.4 | 76.89 | TTM | high |
| PEG | 12M | $120.75 | 24.4 | 4.95 | TTM | high |
| residual income | 12M | $52.95 | — | — | TTM | high |
| triangulated | 12M | $88.07 | 17.4 | 5.07 | Triangulated | high |
| Peer P/E | 3Y | $141.35 | 17.4 | 8.14 | Analyst | medium |
| Peer P/S | 3Y | $129.62 | 1.4 | 89.46 | Analyst | medium |
| PEG | 3Y | $198.67 | 24.4 | 8.14 | Analyst | medium |
| Peer P/E | 5Y | $155.99 | 17.4 | 8.99 | Analyst | medium |
| Peer P/S | 5Y | $143.05 | 1.4 | 98.73 | Analyst | medium |
| PEG | 5Y | $219.25 | 24.4 | 8.99 | Analyst | medium |